To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
143.09+12.68% from last year
Operating profits
30.55+36.57% from last year
Net income
117.35+786.33% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Net worth530.53374.85307.60255.77216.45176.57160.50154.75147.01133.59125.16125.7676.23
Fixed assets171.83113.53124.26103.71113.30122.89127.64130.80136.67109.26104.52106.05102.92
Debt--0.010.581.3711.7236.5054.2244.7422.5833.2314.5162.90
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Operating77.8694.3690.8264.7558.2750.1745.7814.687.3332.81-1.97-5.5612.32
Investing -41.80-79.15-105.81-34.66-7.96-10.70-19.02-15.54-30.06-15.25-10.3159.30-12.13
Financing -27.08-20.31-17.12-13.51-10.49-39.30-26.500.1123.36-17.5812.24-53.65-0.19

Financial ratios

Profitability ratiosinfo2
ROA31.35%
ROE40.48%
ROCE51.79%
EPS110.8%
Net profit margin28.04%
Operating profit margin24.73%
Dividend per share24%
Operational ratiosinfo2
Quick ratio3.11%
Current ratio3.88%
Interest coverage147.47%
Assets turnover1.2%
Debt to equity
Valuation ratiosinfo2
P/E ratio503.27%
P/B ratio
Dividend yield0.95%
EV/EBITDA
RPG Life Sciences a part of RPG Enterprises is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations Global Generics and Synthetic APIs space. The company is a research based pharmaceutical company producing a wide range of quality affordable medicines. The company operates through three business verticals – API Domestic Formulations and International Formulations.
personal

Grow your wealth with more research recommendations

+91